Skip to main content

Table 1 Patients’ clinical profiles

From: Early initiation of tolvaptan is associated with early discharge in patients with heart failure regardless of age

 

 < 80 years old

 ≥ 80 years old

P value

(n = 146)

(n = 101)

Age (years)

67.5 ± 10.0

85.1 ± 3.7

< 0.001

Male (n, %)

94, 64.4

48, 47.5

< 0.001

Height (cm)

160.5 ± 9.0

154.9 ± 8.6

< 0.001

Weight (kg)

56.5 ± 13.5

46.9 ± 9.5

< 0.001

Body mass index (kg/m2)

21.8 ± 4.1

19.5 ± 3.4

< 0.001

NYHA class (II/III/IV)

1/122/23

1/88/12

0.376

CS class (I/II/III)

48/83/15

25/66/10

0.270

Hypertension (n, %)

112, 76.7

82, 81.2

0.402

Diabetes mellitus (n, %)

37, 25.3

23, 22.8

0.645

Dyslipidemia (n, %)

29, 19.9

26, 25.7

0.277

Chronic kidney disease (n, %)

18, 12.3

20, 19.8

0.110

Prior HF hospitalization (n, %)

54, 37.0

45, 44.6

0.234

  1. NYHA: New York Heart Association, CS: clinical scenario, HF: heart failure. Continuous data are expressed as the mean ± standard deviation or error. P-values were determined using the unpaired t-test